Last updated on May 2020

A Study Evaluating the Efficacy and Safety of Etrasimod in the Treatment of Patients With Moderately to Severely Active Crohn's Disease


Brief description of study

The purpose of this study is to evaluate the dose-response relationship of two doses of etrasimod versus placebo as induction therapy in participants with moderately to severely active Crohn's disease and to select an oral etrasimod dose, based on efficacy and safety, for continued development.

Clinical Study Identifier: NCT04173273

Find a site near you

Start Over

Carolina Digestive Diseases

Greenville, NC United States
2.67miles
  Connect »

Carolina Research

Greenville, NC United States
2.67miles
  Connect »